The study found that Boston Scientific’s withdrawal has provided an opening for competitors, which may disproportionately benefit St. Jude. “Boston Scientific’s decision to suspend sales puts one-third of the market up for grabs, an extraordinary opportunity for those positioned to supply the market in the interim,” said Philip Legendy, Director and Senior Medical Device Analyst at Majestic Research. “Given their historical sales footprint, we expected to see Medtronic (MED) outpacing St. Jude’s (STJ) share of the new business at a ratio of about 2 to 1. Our study suggests, however, that St. Jude is running only 13 points of share behind Medtronic in converting physicians who formerly preferred Boston Scientific ICDs.”Majestic Research’s Boston Scientific ICD Withdrawal study encompasses analysis of a targeted Internet survey of 70 electrophysiologists who were surveyed from March 18 to March 24, 2010. The study evaluates physician response to the announcement and field action, the long-term impact on BSX’s ICD devices and overall BSX brand, which competitors will benefit, and what messaging, if any, has been communicated by sales representatives.About Majestic ResearchMajestic Research is an independent financial and market research firm focused exclusively on cutting-edge, data-driven research. Since its inception in 2002, the company has revolutionized the research industry with its unprecedented methods and tools for accessing real-time data. With the acquisition of Rood Research in 2009, Majestic broadened its data gathering to include a best-in-breed survey competence. The healthcare market research practice continues to deliver fast turnaround primary market intelligence of the highest quality. As a division of Majestic, the group combines survey results with proprietary empirical data to deliver a new syndicated and custom reporting capability.With a razor-sharp focus, Majestic specializes in surfacing the hidden metrics that will influence a company’s future performance.Majestic’s financial and market research coverage encompasses leading companies in an array of sectors including Airlines, Casinos, Consumer Technology, Cruise Lines, Hardline Retail, Healthcare, Internet, Lodging, Real Estate, Softline Retail, and Video Games. The company’s capabilities include custom, syndicate, and primary research.To learn more about Majestic’s unique healthcare research capabilities, please contact us directly at: 646.442.6607, e-mail: healthcare@majesticresearch.com and visit our website: www.majesticresearch.comMajestic Research
Patricia Fall, 646-237-4486
Director of Marketing
pfall@majesticresearch.comSource: Majestic ResearchCopyright Business Wire 2010
